Identification of progenitor cancer stem cell in lentigo maligna melanoma

Dermatologic Therapy

Volumn 21, Issue SUPPL. 1, 2008, Pages

  Bongiorno, M R ^a   Doukaki, S ^a   Malleo, F ^a   Arico M ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

CD133; CD34; Lentigo maligna melanoma; Progenitor cancer stem cell

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN;

ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALIGNANT LENTIGO; MELANOMA; PROTEIN EXPRESSION; STEM CELL;

ANTIGENS, CD; ANTIGENS, CD34; BIOLOGICAL MARKERS; GLYCOPROTEINS; HAIR FOLLICLE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; MELANOCYTES; NEOPLASTIC STEM CELLS; PEPTIDES; SKIN NEOPLASMS;

EID: 47749100122     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2008.00193.x     Document Type: Article

References (32)

1. Rodolfo M, Daniotti M, Vallacchi V. Genetic progression of metastatic melanoma. Cancer Lett 2004 : 214 : 133 147.
2. Cramer SF. The histogenesis of acquired melanocytic nevi. Based on a new concept of melanocytic differentiation. Am J Dermatopathol 1984 : 6 : 289 298.
3. Cramer SF. The neoplastic development of malignant melanoma. A biological rationale. Am J Dermatopathol 1984 : 6 : 299 308.
4. Yu HS. Melanocyte destruction and repigmentation in vitiligo: A model for nerve cell damage and regrowth. J Biomed Sci 2002 : 9 : 564 573.
5. Nishimura EK, Jordan SA, Oshima H, et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 2002 : 416 : 854 860.
6. Botchkareva NV, Botchkarev VA, Gilchrest BA. Fate of melanocytes during development of the hair follicle pigmentary unit. J Invest Dermatol Symp Proc 2003 : 8 : 76 79.
7. Kath R, Jambrosic JA, Holland L, et al. Development of invasive and growth factor-independent cell variants from primary human melanomas. Cancer Res 1991 : 51 : 2205 2211.
8. Hendrix M, Seftor EA, Meltzer PS, et al. The stem cell plasticity of aggressive melanoma tumor cells. In : Sell S, ed. Stem cells handbook. Totowa, NJ : Humana Press, Inc., 2003 : 297 306.
9. Reed JA, Finnerty B, Albino AP. Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression. Am J Pathol 1999 : 155 : 549 555.
10. Brocker EB, Magiera H, Herlyn M. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. J Invest Dermatol 1991 : 96 : 662 665.
11. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma. Nat Rev Cancer 2003 : 3 : 411 421.
12. Hsu MY, Shih DT, Meier FE, et al. Adenoviral gene transfer of h3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol 1998 : 153 : 1435 1442.
13. Satyamoorthy K, Muyrers J, Meier F, et al. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Oncogene 2001 : 20 : 4676 4684.
14. Huber MA, Kraut N, Park JE, et al. Fibroblast activation protein: Differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J Invest Dermatol 2003 : 120 : 182 188.
15. Cruz J, Reis-Filho JS, Lopes JM. Primary cutaneous malignant melanoma with lipoblast-like cells. Arch Pathol Laboratory Med 2003 : 127 : 370 371.
16. Giele H, Hollowood K, Gibbons CL, et al. Subungual melanoma with osteocartilaginous differentiation. Skeletal Radiol 2003 : 32 : 724 727.
17. Grichnik JM, Burch JA, Schulteis RD, et al. Melanoma, a tumor based on a mutant stem cell? Invest Dermatol 2006 : 126 : 142 153.
18. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001 : 414 : 105 111.
19. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004 : 51 : 1 28.
20. Liu S, Dontu G, Wicha MS. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 2005 : 7 : 86 95.
21. Dontu G, Jackson KW, McNicholas E, et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 2004 : 6 : 605 615.
22. Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004 : 431 : 707 712.
23. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004 : 306 : 1568 1571.
24. Krivtsov AV, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006 : 442 : 818 822.
25. Oshima H, Rochat A, Kedzia C, et al. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 2001 : 104 : 233 245.
26. Amoh Y, Li L, Katsuoka K, et al. Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci USA 2005 : 102 : 5530 5534.
27. Albert MR, Foster RA, Vogel JC. Murine epidermal label-retaining cells isolated by flow cytometry do not express the stem cell markers CD34, Sca-1, or Flk-1. J Invest Dermatol 2001 : 117 : 943 948.
28. Yin AH, Miraglia S, Zanjani ED, et al. AC133 a novel marker for human hematopoietic stem and progenitor cells. Blood 1997 : 90 : 5002 5012.
29. Shmelkov SV, St Clair R, Lyden D, et al. AC133/CD133/Prominin-1. Int J Biochem Cell Biol 2005 : 37 : 715 719.
30. Florek M, Haase M, Marzesco AM, et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 2005 : 319 : 15 26.
31. Belicchi M, Pisati F, Lopa R, et al. Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res 2004 : 77 : 475 486.
32. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004 : 432 : 396 401.